ImmuCell Co. (NASDAQ:ICCC – Get Free Report)’s stock price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $3.96 and traded as high as $4.63. ImmuCell shares last traded at $4.41, with a volume of 24,463 shares traded.
ImmuCell Stock Performance
The company has a quick ratio of 1.44, a current ratio of 3.11 and a debt-to-equity ratio of 0.36. The stock has a market cap of $39.30 million, a P/E ratio of -8.82 and a beta of 0.60. The firm’s 50-day moving average is $3.93 and its two-hundred day moving average is $3.96.
About ImmuCell
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company operates through two segments, Scours and Mastitis. It offers First Defense, an orally delivered scours preventive product for calves with claims against E.
Read More
- Five stocks we like better than ImmuCell
- What is an Earnings Surprise?
- XPO Stock Gains Momentum as U.S. Trade Outlook Evolves
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- CarMax Gets in Gear: Is Now the Time to Buy?
- Trading Halts Explained
- Qubit Combat: 2 Stocks Battle for Quantum Supremacy
Receive News & Ratings for ImmuCell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuCell and related companies with MarketBeat.com's FREE daily email newsletter.
